(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 63.90%439.76M | 58.13%413.35M | 52.11%367.74M | 31.99%1.08B | 43.20%311.11M | 27.38%268.31M | 31.89%261.4M | 24.53%241.76M | 31.13%820.22M | 25.56%217.25M |
Operating revenue | 63.90%439.76M | 58.13%413.35M | 52.11%367.74M | 31.99%1.08B | 43.20%311.11M | 27.38%268.31M | 31.89%261.4M | 24.53%241.76M | 31.13%820.22M | 25.56%217.25M |
Cost of revenue | 14.05%168.01M | 18.88%170.18M | 7.44%159.14M | 29.28%589.83M | 18.82%151.25M | 26.43%147.31M | 31.04%143.15M | 43.51%148.12M | 43.29%456.26M | 35.24%127.29M |
Gross profit | 124.59%271.75M | 105.63%243.17M | 122.79%208.6M | 35.38%492.74M | 77.70%159.86M | 28.55%121M | 32.93%118.26M | 2.99%93.63M | 18.53%363.97M | 14.01%89.96M |
Operating expense | 34.10%311.09M | 24.45%287.07M | 21.98%282.92M | 3.75%938.99M | 5.46%244.39M | 8.82%231.98M | -0.59%230.68M | 1.70%231.93M | 16.74%905.01M | 6.02%231.73M |
Selling and administrative expenses | 38.39%214.15M | 29.81%197.97M | 29.84%194.28M | 5.05%618.31M | 12.24%161.43M | 4.79%154.74M | 2.03%152.51M | 1.35%149.63M | 15.18%588.59M | -2.00%143.82M |
Research and development costs | 25.50%96.93M | 13.99%89.11M | 7.69%88.64M | 1.35%320.68M | -5.63%82.96M | 17.90%77.24M | -5.34%78.17M | 2.35%82.31M | 19.76%316.42M | 22.42%87.91M |
Operating profit | 64.55%-39.34M | 60.95%-43.9M | 46.27%-74.31M | 17.52%-446.25M | 40.37%-84.54M | 6.78%-110.98M | 21.43%-112.43M | -0.85%-138.3M | -15.56%-541.04M | -1.51%-141.77M |
Net non-operating interest income expense | 293.50%8.48M | 446.61%7.33M | 368.70%7.14M | 302.65%11.72M | 1,866.75%6.7M | 196.03%2.15M | 171.60%1.34M | 218.51%1.52M | -97.71%-5.78M | 59.16%-379K |
Non-operating interest income | 114.91%11.62M | 131.45%10.46M | 123.93%10.27M | 588.33%24.35M | 314.83%9.84M | 6,113.79%5.41M | 1,531.05%4.52M | 472.41%4.59M | -34.25%3.54M | 106.17%2.37M |
Non-operating interest expense | -3.38%3.14M | -1.57%3.13M | 2.06%3.12M | 35.62%12.64M | 14.39%3.15M | 39.57%3.25M | 47.77%3.18M | 46.67%3.06M | 12.21%9.32M | 32.37%2.75M |
Other net income (expense) | ||||||||||
Income before tax | 71.64%-30.86M | 67.08%-36.57M | 50.89%-67.17M | 20.54%-434.53M | 45.24%-77.84M | 10.28%-108.83M | 23.37%-111.09M | 1.18%-136.78M | -16.07%-546.82M | -1.11%-142.15M |
Income tax | 261.39%730K | 416.31%892K | 167.50%428K | -72.29%271K | -54.63%191K | 9.19%202K | -246.11%-282K | -10.61%160K | 58.25%978K | 1,503.33%421K |
Net income | 71.02%-31.59M | 66.19%-37.46M | 50.63%-67.6M | 20.63%-434.8M | 45.27%-78.03M | 10.25%-109.03M | 23.66%-110.8M | 1.20%-136.94M | -16.13%-547.8M | -1.43%-142.57M |
Net income continuous Operations | 71.02%-31.59M | 66.19%-37.46M | 50.63%-67.6M | 20.63%-434.8M | 45.27%-78.03M | 10.25%-109.03M | 23.66%-110.8M | 1.20%-136.94M | -16.13%-547.8M | -1.43%-142.57M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 71.02%-31.59M | 66.19%-37.46M | 50.63%-67.6M | 20.63%-434.8M | 45.27%-78.03M | 10.25%-109.03M | 23.66%-110.8M | 1.20%-136.94M | -16.13%-547.8M | -1.43%-142.57M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 71.02%-31.59M | 66.19%-37.46M | 50.63%-67.6M | 20.63%-434.8M | 45.27%-78.03M | 10.25%-109.03M | 23.66%-110.8M | 1.20%-136.94M | -16.13%-547.8M | -1.43%-142.57M |
Basic earnings per share | 72.63%-0.26 | 69.07%-0.3 | 54.47%-0.56 | 32.14%-3.78 | 53.28%-0.64 | 24.00%-0.95 | 35.33%-0.97 | 15.17%-1.23 | -6.91%-5.57 | 8.05%-1.37 |
Diluted earnings per share | 72.63%-0.26 | 69.07%-0.3 | 54.47%-0.56 | 32.14%-3.78 | 53.28%-0.64 | 24.00%-0.95 | 35.33%-0.97 | 15.17%-1.23 | -6.91%-5.57 | 8.05%-1.37 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
No Data
No Data